|1.||Zhong, Zhiyuan: 5 articles (03/2014 - 08/2011)|
|2.||Meng, Fenghua: 5 articles (03/2014 - 08/2011)|
|3.||Wei, Yuquan: 5 articles (01/2014 - 06/2011)|
|4.||Mei, Lin: 4 articles (10/2015 - 01/2009)|
|5.||Qian, Zhiyong: 4 articles (01/2014 - 06/2011)|
|6.||Kwon, Glen S: 4 articles (01/2014 - 11/2011)|
|7.||Cho, Hyunah: 4 articles (01/2014 - 11/2011)|
|8.||Wang, Jun: 4 articles (10/2012 - 04/2011)|
|9.||Huang, Laiqiang: 3 articles (10/2015 - 01/2009)|
|10.||Mikos, Antonios G: 3 articles (08/2015 - 05/2012)|
11/30/2015 - "We studied the transfer of Pheo from poly(ethyleneglycol-b-ϵ-caprolactone) nanoparticles (I) to MCF-7 cancer cells and (II) to models of membranes. "
07/01/2015 - "In addition, both nanoformulations produced in vivo an intense tumor growth inhibition and increased the mice survival rate, being the greater tumor volume reduction obtained when using the poly(ε-caprolactone)-based formulation. "
04/01/2013 - "Efficacy of methotrexate-loaded poly(ε-caprolactone) implants in Ehrlich solid tumor-bearing mice."
04/01/2014 - "In this study, the effects of the controlled and sustained release of methotrexate from poly(ɛ-caprolactone) implants were evaluated in the solid Ehrlich tumor. "
01/01/2012 - "The main aim of this study was to develop and evaluate nanoparticulate system of paclitaxel loaded polymeric biodegradable Poly (ε-caprolactone) nanoparticles for targeting to neuroendocrine pancreatic tumors in mice. "
|2.||Wounds and Injuries (Trauma)
04/01/2012 - "Electrospun gelatin and poly-ε-caprolactone (PCL) nanofibers were prepared using needleless technology and their biocompatibility and therapeutic efficacy have been characterized in vitro in cell cultures and in an experimental model of a skin wound. "
03/01/2015 - "Outstanding wound healing activity of gum tragacanth (GT) and higher mechanical strength of poly (ε-caprolactone) (PCL) may produce an excellent nanofibrous patch for either skin tissue engineering or wound dressing application. "
07/01/2014 - "For the first time, it has been tried to achieve optimum conditions for electrospun poly(ε-caprolactone)/polystyrene (PCL/PS) nanofibrous samples as active wound dressings containing chamomile via D-optimal design approach. "
01/01/2015 - "Here, we report a novel chloramphenicol loaded with poly(ε-caprolactone) (PCL)-pluronic composite nanoparticles (CAM-PCL-P NPs), physicochemical characterizations, and its bioactivity evaluation in a MRSA-infected burn-wound animal model. "
01/01/2015 - "Chloramphenicol encapsulated in poly-ε-caprolactone-pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds."
|4.||Breast Neoplasms (Breast Cancer)
12/23/2015 - "Porous poly(ε-caprolactone) (PCL) scaffolds of modulus 7.0 ± 0.5 kPa, comparable to that of breast tumor tissue were fabricated, on which MDA-MB-231 cells proliferated forming tumoroids. "
01/01/2015 - "Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery."
10/01/2011 - "Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy."
01/01/2009 - "The purpose of this research is to test the possibility of docetaxel-loaded poly (ε-caprolactone)/Pluronic F68 (PCL/Pluronic F68) nanoparticles to overcome MDR in docetaxel-resistance human breast cancer cell line. "
01/01/2009 - "A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment."
|5.||Lung Neoplasms (Lung Cancer)
01/01/2014 - "An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion."
01/01/2012 - "Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells."
02/13/2012 - "Use of the stearic acid-conjugated poly(glycerol-co-caprolactone) films afforded substantial anticancer activity in vitro for at least 50 days when exposed to fresh cultures of A549 human lung cancer cells over 24 h intervals, correlating well with the measured drug release kinetics."
01/01/2013 - "Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy."
01/01/2013 - "In order to improve the therapeutic efficacy and minimize the side effects of lung cancer chemotherapy, the formulation of paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles (PTX-loaded [PGA-co-PCL]-b-TPGS2k NPs) was prepared. "
|1.||Ethylene Glycol (Monoethylene Glycol)
|8.||Prostaglandins A (PGA)
|10.||poly(epsilon- caprolactone)- b- poly(ethyleneglycol)- b- poly(epsilon- caprolactone)
|1.||Drug Therapy (Chemotherapy)